Cite
Fonteneau G, Bony C, Goulabchand R, et al. Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function. Front Immunol. 2017;8:988doi: 10.3389/fimmu.2017.00988.
Fonteneau, G., Bony, C., Goulabchand, R., Maria, A. T. J., Le Quellec, A., Rivière, S., Jorgensen, C., Guilpain, P., & Noël, D. (2017). Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function. Frontiers in immunology, 8988. https://doi.org/10.3389/fimmu.2017.00988
Fonteneau, Guillaume, et al. "Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function." Frontiers in immunology vol. 8 (2017): 988. doi: https://doi.org/10.3389/fimmu.2017.00988
Fonteneau G, Bony C, Goulabchand R, Maria ATJ, Le Quellec A, Rivière S, Jorgensen C, Guilpain P, Noël D. Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function. Front Immunol. 2017 Sep 01;8:988. doi: 10.3389/fimmu.2017.00988. eCollection 2017. PMID: 28919892; PMCID: PMC5585199.
Copy
Download .nbib